ACADIA PHARMACEUTICALS INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Acadia Pharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2024.
  • Acadia Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $33.4M, a 2897% increase year-over-year.
  • Acadia Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $30.6M.
  • Acadia Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$61.3M, a 71.6% increase from 2022.
  • Acadia Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$216M, a 28.7% decline from 2021.
  • Acadia Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$168M, a 40.4% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $30.6M $33.4M +$32.3M +2897% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$1.71M $16.6M +$59.6M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$61.3M $45.8M +$87.5M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$149M -$65.2M -$38M -140% Jul 1, 2023 Sep 30, 2023 10-K 2024-02-28
Q2 2023 -$111M $1.11M +$35.1M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$146M -$43M +$70M +61.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$216M -$41.7M +$1.37M +3.18% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$217M -$27.2M -$12.7M -88% Jul 1, 2022 Sep 30, 2022 10-K 2024-02-28
Q2 2022 -$205M -$34M +$9.86M +22.5% Apr 1, 2022 Jun 30, 2022 10-K 2024-02-28
Q1 2022 -$214M -$113M -$46.6M -70.1% Jan 1, 2022 Mar 31, 2022 10-K 2024-02-28
Q4 2021 -$168M -$43.1M +$23.7M +35.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 -$192M -$14.5M +$70.2M +82.9% Jul 1, 2021 Sep 30, 2021 10-K 2023-02-28
Q2 2021 -$262M -$43.9M -$1.73M -4.11% Apr 1, 2021 Jun 30, 2021 10-K 2023-02-28
Q1 2021 -$260M -$66.4M +$21.6M +24.5% Jan 1, 2021 Mar 31, 2021 10-K 2023-02-28
Q4 2020 -$282M -$66.8M -$13.7M -25.9% Oct 1, 2020 Dec 30, 2020 10-K 2022-03-01
Q3 2020 -$268M -$84.7M -$42.7M -102% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-01
Q2 2020 -$225M -$42.1M +$12.8M +23.3% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-01
Q1 2020 -$238M -$88M -$2.72M -3.19% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-01
Q4 2019 -$235M -$53M +$12.5M +19% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$248M -$42M +$20.2M +32.4% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-25
Q2 2019 -$268M -$54.9M +$8.33M +13.2% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-25
Q1 2019 -$276M -$85.3M -$31M -57.1% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-25
Q4 2018 -$245M -$65.5M +$3.38M +4.91% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$249M -$62.1M +$3.11M +4.77% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 -$252M -$63.3M +$4.18M +6.19% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 -$256M -$54.3M +$33.5M +38.2% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q4 2017 -$289M -$68.9M +$9.83M +12.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 -$299M -$65.2M +$6.37M +8.89% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 -$306M -$67.4M +$3.88M +5.44% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-27
Q1 2017 -$309M -$87.8M -$38.1M -76.5% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-27
Q4 2016 -$271M -$78.7M -$32.9M -71.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-27
Q3 2016 -$238M -$71.6M -$32.7M -84.1% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-27
Q2 2016 -$206M -$71.3M -$31.9M -81.1% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-27
Q1 2016 -$174M -$49.8M -$9.39M -23.3% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-27
Q4 2015 -$164M -$45.8M -$17.4M -61.4% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-28
Q3 2015 -$147M -$38.9M -$14.1M -57% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-28
Q2 2015 -$133M -$39.4M -$17.9M -83.2% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-28
Q1 2015 -$115M -$40.4M -$22.5M -126% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-28
Q4 2014 -$92.5M -$28.4M -$16.3M -135% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-29
Q3 2014 -$76.2M -$24.8M -$14.1M -132% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-29
Q2 2014 -$62.1M -$21.5M -$12.4M -137% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-29
Q1 2014 -$49.7M -$17.8M -$11.7M -191% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-29
Q4 2013 -$37.9M -$12M -$5.24M -76.9% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-26
Q3 2013 -$32.7M -$10.7M -$8.29M -345% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-26
Q2 2013 -$24.4M -$9.08M -$3.66M -67.6% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-26
Q1 2013 -$20.8M -$6.12M +$95K +1.53% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-26
Q4 2012 -$20.8M -$6.81M -$1.51M -28.5% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-27
Q3 2012 -$19.3M -$2.4M +$2.67M +52.7% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-27
Q2 2012 -$22M -$5.42M +$1.14M +17.3% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-27
Q1 2012 -$23.2M -$6.22M -$385K -6.6% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-27
Q4 2011 -$22.8M -$5.3M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-12
Q3 2011 -$5.08M -$849K -20.1% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-12
Q2 2011 -$6.56M -$2.27M -52.9% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-12
Q1 2011 -$5.83M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-12
Q3 2010 -$4.23M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 -$4.29M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.